High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study, Proffered paper (oral presentation) 187O

Steenbruggen, T. G., Steggink, L., Seynaeve, C. M., van der Hoeven, JJM., Hooning, M. J., Jager, A., Konings, IR., Kroep, J. R., Smit, WM., Tjan-Heijnen, V. C. G., van der Wall, E., Bins, AD., Linn, SC., Schaapveld, M., van Leeuwen, FE., Schroder, C., van Tinteren, H., de Vries, E. G. E., Sonke, G. S. & Gietema, J. A., 2018.

Research output: Contribution to conferenceAbstractAcademic

Original languageEnglish
Publication statusPublished - 2018
EventEuropean Society for Medical Oncology 2018 meeting -
Duration: 19-Oct-201823-Oct-2018


ConferenceEuropean Society for Medical Oncology 2018 meeting


European Society for Medical Oncology 2018 meeting


Event: Conference

View graph of relations

ID: 66420526